Wegovy is easier to buy in 2026 than ever before.
The brand expanded into a daily oral pill (alongside the weekly injection pen), opened multiple direct-to-consumer pharmacy paths, and slashed self-pay pricing to $149 a month for the tablet form. Hims & Hers added Wegovy in March 2026. LifeMD, Walgreens, and NovoCare's own pharmacy all ship the medication directly. Cash retail at $1,349 a month is no longer the only option. Here's exactly where to buy Wegovy online in 2026, what each route actually costs, whether you qualify, and how the new oral pill changes the math.
🔑 Key Takeaways
- Wegovy is now available as both a daily pill ($149/mo through NovoCare) and a weekly injection pen ($349/mo standard self-pay).
- Cheapest legitimate path: NovoCare direct at $149/mo for tablets, or $25/mo with eligible commercial insurance via the savings card.
- Top online providers in 2026: NovoCare (manufacturer direct), MEDVi, Hims & Hers (launched March 2026), LifeMD, Walgreens, Ro, Noom Med, and Sesame Care.
- Eligibility: BMI 30+ (obesity) or BMI 27+ with a weight-related comorbidity (T2D, hypertension, sleep apnea, hyperlipidemia, NAFLD).
- The oral pill (1.5mg, 4mg, or 25mg daily) is for adults who can't or won't inject. Clinical results are slightly lower than the injection: 1 in 4 pill users vs 1 in 3 injection users hit 20%+ weight loss.
Here's what each route actually delivers in 2026.
Where to buy Wegovy online in 2026
Eight legitimate routes, each with a different price tier and access profile.
| Provider | Form | Self-pay starting | Insurance | Time to first dose |
|---|---|---|---|---|
| NovoCare (direct from manufacturer) | Pill or pen | $149 (pill) / $349 (pen) | Yes ($25 savings card) | 5 to 7 days |
| MEDVi | Pill or pen | $99 membership + medication | Membership only | 5 to 7 days |
| Hims & Hers | Pill or pen | $39 first month, $149 after | Membership only | 3 to 5 days |
| LifeMD | Pill or pen | $149 (pill) / $199 (pen) + $75 program fee | Yes ($0 to $25 copay) | 5 to 7 days |
| Walgreens Virtual Care | Pen | Pricing varies by store | Yes (insurance-first) | 3 to 7 days |
| PlushCare | Pen | $19.99 (with insurance) | Yes (in-network) | 5 to 10 days |
| Ro Body | Pen | $145 + $45 consult | Yes (navigates coverage) | 5 to 7 days |
| Amazon Pharmacy | Pen | $0 to $14.99 (with insurance) | Yes | 2 to 5 days |
Cheapest legitimate path: NovoCare direct at $149/mo for tablets
The Wegovy oral pill from NovoCare's own pharmacy is the cheapest cash-pay option in 2026 at $149/month for the 1.5mg or 4mg tablet (the 4mg promotional price runs through August 31, 2026). For the weekly injection pen, NovoCare self-pay is $349/month at standard doses. If you have eligible commercial insurance, the Wegovy Savings Card brings out-of-pocket as low as $25/month with a $100 maximum monthly savings. Medicare, Medicaid, VA, DOD, and TRICARE patients are excluded from the savings card but Medicare started covering Wegovy in 2025 for patients with cardiovascular disease and obesity.
Wegovy cash price in 2026: every option ranked
Cash retail Wegovy without any program runs around $1,349 for a one-month supply of pens. That's the starting point. Every legitimate route below saves significant money on that retail figure.
- NovoCare oral pill (tablet): $149/month for 1.5mg or 4mg, $199/month for 0.25mg or 0.5mg (through June 30, 2026). The cheapest legitimate Wegovy in 2026.
- Insurance copay (when covered): $0 to $100/month with prior auth. Plans that cover obesity medications are still in the minority but growing.
- NovoCare injection pen: $349/month standard self-pay, $399/month for HD 7.2mg.
- Wegovy Savings Card: As low as $25/month with eligible commercial insurance, $100 maximum monthly savings. Excludes government insurance.
- Telehealth platforms (MEDVi, LifeMD, Hims/Hers): Membership $39 to $99/month + medication priced through NovoCare partnership. Bundled total typically lands at $200 to $400.
- Cash retail without any program: $1,060 to $1,349/month at chain pharmacies (Walgreens, CVS, Walmart). The most expensive route.
Wegovy pill vs Wegovy pen: which form to buy
The biggest 2026 update is the oral tablet. Wegovy is now available as a daily pill alongside the original weekly injection pen. Same active molecule (semaglutide), different delivery.
| Wegovy Pill (oral tablet) | Wegovy Pen (subcutaneous injection) | |
|---|---|---|
| Active ingredient | Semaglutide (oral form) | Semaglutide (injectable form) |
| Dosing schedule | Daily, 30 minutes before first food/water | Once weekly |
| Available strengths | 1.5mg, 4mg, 25mg tablets | 0.25, 0.5, 1, 1.7, 2.4, 7.2mg |
| NovoCare self-pay | $149/mo | $349/mo standard, $399/mo HD |
| Trial weight loss | About 1 in 4 reach 20%+ loss | About 1 in 3 reach 20%+ loss |
| Best for | Needle-averse patients, simpler dosing | Maximum potency, better adherence for some |
| Tradeoff | Lower bioavailability requires daily empty-stomach dosing | Weekly injection, slightly higher peak weight loss |
The pill works for patients who specifically don't want injections, can commit to a strict morning empty-stomach dosing routine (no food, no other medications, no coffee for 30 minutes), and accept slightly lower peak efficacy. The pen remains the higher-efficacy option and the original FDA-approved formulation. Most clinicians still default to the pen unless a patient has a specific reason to prefer oral.
For a deeper breakdown of the oral form specifically, see our Wegovy pill complete guide.
Do you qualify for Wegovy? Eligibility in 2026
The FDA-approved indication for Wegovy is well-defined. You qualify if you meet any of these criteria:
- BMI 30 or higher (general obesity in adults)
- BMI 27 or higher with at least one weight-related comorbidity:
- Type 2 diabetes
- Hypertension (high blood pressure)
- Hyperlipidemia (high cholesterol)
- Obstructive sleep apnea
- Cardiovascular disease
- NAFLD or MASH (fatty liver)
- Children 12 and older with BMI in the 95th percentile or higher (FDA-approved 2022)
- Cardiovascular risk reduction for adults with established CVD and obesity (FDA-approved March 2024)
You don't qualify if any of these apply:
- Pregnancy or planning pregnancy in next 2 months
- Currently breastfeeding
- Personal or family history of medullary thyroid cancer or MEN-2
- Active pancreatitis or recent pancreatic disease
- Type 1 diabetes (relative contraindication)
- Severe gastroparesis
- Allergy to semaglutide or any pen component
If you fall outside these criteria but have a clinical case for off-label use, some telehealth providers will prescribe compounded semaglutide (the same active molecule) through a 503A pharmacy at lower cost. That's covered in our GLP-1 prescription online guide.
How to get prescribed Wegovy online: the actual process
Same six-step process most online prescriptions follow, with Wegovy-specific notes at each step.
- Choose a platform. NovoCare for direct manufacturer pricing. MEDVi for membership-plus-medication with the cheapest branded pen access. Hims/Hers if you already use their ecosystem. Walgreens or LifeMD if you want insurance-first navigation.
- Complete the medical intake. 10 to 20 minutes. Cover your weight history, BMI, medications, allergies, family history (especially thyroid cancer), and any current GLP-1 medication use.
- Provider evaluation. Most platforms run async (provider reviews your form within 24 to 72 hours). LifeMD and Walgreens typically use synchronous video visits.
- Insurance check (if relevant). Platforms like Walgreens, LifeMD, and PlushCare verify your insurance coverage before processing the prescription. NovoCare direct skips this if you're paying self-pay.
- Prescription routes to a pharmacy. NovoCare ships from their own pharmacy network. Other platforms route to specialty pharmacies (typically same NovoCare-affiliated pharmacies for direct branded fulfillment).
- Ongoing dose adjustment. Wegovy uses a structured dose-escalation schedule (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg over 16 to 20 weeks for the pen). Your provider should be available for dose adjustments and side-effect management at each titration step.
Total time from sign-up to first dose: typically 5 to 10 days for branded Wegovy. The bottleneck is usually insurance authorization or pharmacy fulfillment, not the consultation itself.
Wegovy alternatives if you don't qualify or want lower cost
Several options sit alongside Wegovy in the GLP-1 weight-loss space, each with different tradeoffs.
| Alternative | What it is | Monthly cost | Trial weight loss |
|---|---|---|---|
| Compounded semaglutide | Same molecule, prepared by 503A pharmacy | $58 to $199 | Same as branded (14.9%) |
| Zepbound (tirzepatide) | Dual GLP-1 + GIP, often higher peak loss | $349 to $1,060 | 22.5% Phase 3 |
| Compounded tirzepatide | Same as Zepbound, compounded | $99 to $299 | 22.5% |
| Mounjaro (tirzepatide for diabetes) | Diabetes brand, same molecule as Zepbound | $25 to $549 | 22.5% |
| Ozempic (semaglutide for diabetes) | Diabetes brand, same molecule as Wegovy | $25 to $1,029 | 14.9% (off-label for weight) |
| Saxenda (liraglutide) | Older daily-injection GLP-1 | $1,300+ retail | 5.4% |
| Retatrutide (peptide vials only) | Triple GLP-1/GIP/glucagon, not yet approved | $120 to $250 (vials) | 24.2% Phase 2 |
If cost is the bottleneck, compounded semaglutide is the closest alternative at one-third the price with the same active molecule. If you've stalled on Wegovy and want maximum weight loss, Zepbound (tirzepatide) is the next step up at slightly higher cost. For complete details on each path, see our cheapest GLP-1 in 2026 guide.
Frequently asked questions
Medical disclaimer. This article is for general information only. Wegovy is a prescription medication that requires evaluation by a licensed clinician. Talk to your provider before starting treatment, especially if you are pregnant, breastfeeding, taking other medications, or have a personal or family history of medullary thyroid cancer or MEN-2.